These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21955239)

  • 1. miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer.
    Gao W; Xu J; Shu YQ
    Expert Rev Respir Med; 2011 Oct; 5(5):699-709. PubMed ID: 21955239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
    Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
    Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
    Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
    Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Personalizing" therapy for non-small cell lung cancer.
    D'Cunha J
    Semin Thorac Cardiovasc Surg; 2010; 22(2):118-20. PubMed ID: 21092888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA as a new factor in lung and esophageal cancer.
    Billeter AT; Barnett RE; Druen D; Polk HC; van Berkel VH
    Semin Thorac Cardiovasc Surg; 2012; 24(3):155-65. PubMed ID: 23200070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
    Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNAs as biomarkers and therapeutic targets in cancer.
    Heneghan HM; Miller N; Kerin MJ
    Curr Opin Pharmacol; 2010 Oct; 10(5):543-50. PubMed ID: 20541466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD.
    Leidinger P; Keller A; Borries A; Huwer H; Rohling M; Huebers J; Lenhof HP; Meese E
    Lung Cancer; 2011 Oct; 74(1):41-7. PubMed ID: 21388703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer.
    Wang J; Wang Q; Liu H; Hu B; Zhou W; Cheng Y
    Cancer Lett; 2010 Nov; 297(2):137-43. PubMed ID: 20797817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells.
    Shin S; Cha HJ; Lee EM; Lee SJ; Seo SK; Jin HO; Park IC; Jin YW; An S
    Int J Oncol; 2009 Jul; 35(1):81-6. PubMed ID: 19513554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
    Tomaszek SC; Huebner M; Wigle DA
    Expert Rev Respir Med; 2010 Aug; 4(4):499-508. PubMed ID: 20658911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis.
    Boeri M; Pastorino U; Sozzi G
    Cancer J; 2012; 18(3):268-74. PubMed ID: 22647364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment.
    Feng B; Zhang K; Wang R; Chen L
    Clin Sci (Lond); 2015 May; 128(10):619-34. PubMed ID: 25760961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
    Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W
    J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implication of microrna for lung cancer.
    Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
    Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in breast cancer pathogenesis.
    Götte M
    Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular prognostication of non-small cell lung cancer.
    Tsao MS; Jablons DM
    Semin Thorac Cardiovasc Surg; 2013; 25(1):4-7. PubMed ID: 23800523
    [No Abstract]   [Full Text] [Related]  

  • 18. Epigenetic biomarkers in lung cancer.
    Liloglou T; Bediaga NG; Brown BR; Field JK; Davies MP
    Cancer Lett; 2014 Jan; 342(2):200-12. PubMed ID: 22546286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression and function of miRNA-451 in non-small cell lung cancer.
    Wang XC; Tian LL; Jiang XY; Wang YY; Li DG; She Y; Chang JH; Meng AM
    Cancer Lett; 2011 Dec; 311(2):203-9. PubMed ID: 21875770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic immune markers in non-small cell lung cancer.
    Suzuki K; Kachala SS; Kadota K; Shen R; Mo Q; Beer DG; Rusch VW; Travis WD; Adusumilli PS
    Clin Cancer Res; 2011 Aug; 17(16):5247-56. PubMed ID: 21659461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.